생명 공학 주식
| 상징 | 명칭 |
가격
(시간 외 거래 |
%(1D) | 거래량 | 시가총액 | 가격 차트 (1D) â–¾ | |
|---|---|---|---|---|---|---|---|
|
Vertex Pharmaceuticals Inc
|
499.74
|
-1.77% |
1.41M |
126.66B |
|
||
|
Moderna, Inc. Common Stock
|
218.01
|
-7.82% |
21.35M |
87.04B |
|
||
|
Regeneron Pharmaceuticals Inc
|
790.74
|
-0.70% |
649.30K |
81.41B |
|
||
|
argenx SE American Depositary Shares
|
819.14
|
-3.21% |
388.97K |
51.51B |
|
||
|
BeOne Medicines Ltd. American Depositary Shares
|
369.06
|
-1.34% |
422.24K |
41.75B |
|
||
|
Revolution Medicines, Inc. Common Stock
|
177.96
|
-5.97% |
2.97M |
38.14B |
|
||
|
Alnylam Pharmaceuticals, Inc.
|
231.83
|
-0.94% |
1.40M |
31.02B |
|
||
|
Royalty Pharma plc Class A Ordinary Shares
|
60.96
|
+2.25% |
5.79M |
27.14B |
|
||
|
Roivant Sciences Ltd. Common Shares
|
33.53
|
-1.50% |
4.92M |
24.22B |
|
||
|
Incyte Genomics Inc
|
113.07
|
-0.18% |
1.58M |
22.92B |
|
||
|
Genmab A/S ADS
|
37.00
|
-2.17% |
2.68M |
22.75B |
|
||
|
BioNTech SE American Depositary Share
|
87.71
|
-2.76% |
1.10M |
22.03B |
|
||
|
Insmed, Inc.
|
96.27
|
-2.96% |
2.40M |
21.02B |
|
||
|
Exelixis Inc
|
62.23
|
-0.95% |
2.64M |
15.42B |
|
||
|
Ascendis Pharma A/S Ordinary Share
|
225.25
|
-0.60% |
680.31K |
14.82B |
|
||
|
Halozyme Therapeutics, Inc.
|
121.84
|
+0.27% |
2.08M |
13.83B |
|
||
|
Jazz Pharmaceuticals, Inc.
|
210.23
|
-1.95% |
636.18K |
13.65B |
|
||
|
BridgeBio Pharma, Inc. Common Stock
|
66.39
|
-1.10% |
2.06M |
12.98B |
|
||
|
Corcept Therapeutics Inc.
|
110.16
|
-2.83% |
849.64K |
11.91B |
|
||
|
Summit Therapeutics Inc. Common Stock
|
14.63
|
-4.81% |
4.31M |
11.67B |
|
||
|
Bio-Techne Corp.
|
72.57
|
+0.07% |
2.65M |
11.38B |
|
||
|
BioMarin Pharmaceuticals Inc
|
54.68
|
-2.44% |
2.62M |
10.58B |
|
||
|
Madrigal Pharmaceuticals, Inc. Common Stock
|
449.74
|
-2.19% |
364.53K |
10.39B |
|
||
|
Vaxcyte, Inc. Common Stock
|
63.62
|
-2.53% |
3.37M |
10.01B |
|
||
|
ImmunityBio, Inc. Common Stock
|
9.18
|
-8.20% |
21.43M |
9.73B |
|
||
|
Krystal Biotech, Inc. Common Stock
|
316.58
|
-4.07% |
226.11K |
9.37B |
|
||
|
Twist Bioscience Corporation Common Stock
|
132.75
|
-8.13% |
2.82M |
8.80B |
|
||
|
Kymera Therapeutics, Inc. Common Stock
|
104.78
|
-3.11% |
488.56K |
8.71B |
|
||
|
Caris Life Sciences, Inc. Common Stock
|
30.56
|
-3.78% |
2.72M |
8.64B |
|
||
|
Cytokinetics Inc.
|
61.95
|
-3.08% |
1.20M |
8.61B |
|
||
|
Protagonist Therapeutics, Inc
|
128.75
|
-5.71% |
886.73K |
8.33B |
|
||
|
TG Therapeutics, Inc.
|
53.97
|
-3.62% |
1.77M |
8.26B |
|
||
|
Axsome Therapeutics, Inc
|
157.14
|
-2.87% |
873.08K |
8.23B |
|
||
|
ARROWHEAD PHARMACEUTICALS, INC.
|
55.90
|
-4.44% |
1.77M |
7.90B |
|
||
|
Abivax SA American Depositary Shares
|
88.13
|
-4.60% |
1.30M |
7.69B |
|
||
|
Spyre Therapeutics, Inc. Common Stock
|
79.90
|
-0.25% |
1.27M |
7.47B |
|
||
|
Ionis Pharmaceuticals, Inc. Common Stock
|
42.94
|
-2.67% |
1.67M |
7.14B |
|
||
|
Praxis Precision Medicines, Inc. Common Stock
|
241.76
|
-2.61% |
499.62K |
6.75B |
|
||
|
Iovance Biotherapeutics, Inc. Common Stock
|
13.62
|
-7.47% |
12.15M |
6.17B |
|
||
|
Rhythm Pharmaceuticals, Inc. Common Stock
|
86.17
|
-2.05% |
364.06K |
5.93B |
|
||
|
Ligand Pharmaceuticals Inc.
|
295.54
|
-0.99% |
164.50K |
5.89B |
|
||
|
Belite Bio, Inc American Depositary Shares
|
142.78
|
-6.45% |
177.23K |
5.75B |
|
||
|
Immunovant, Inc. Common Stock
|
26.73
|
-2.84% |
1.46M |
5.52B |
|
||
|
Kodiak Sciences Inc Common Stock
|
85.75
|
-2.69% |
1.12M |
5.39B |
|
||
|
CG Oncology, Inc. Common stock
|
59.85
|
-3.25% |
1.08M |
5.31B |
|
||
|
Mirum Pharmaceuticals, Inc. Common Stock
|
80.14
|
-2.73% |
462.92K |
5.20B |
|
||
|
Cogent Biosciences, Inc. Common Stock
|
29.52
|
+0.03% |
2.78M |
5.12B |
|
||
|
PTC Therapeutics, Inc.
|
59.24
|
-2.87% |
787.55K |
4.94B |
|
||
|
Scholar Rock Holding Corporation Common Stock
|
39.90
|
-1.82% |
2.89M |
4.86B |
|
||
|
Oruka Therapeutics, Inc. Common Stock
|
71.93
|
-2.63% |
1.38M |
4.76B |
|
||
|
CRISPR Therapeutics AG
|
49.25
|
-4.41% |
1.52M |
4.76B |
|
||
|
Erasca, Inc. Common Stock
|
13.39
|
-9.95% |
7.09M |
4.68B |
|
||
|
Travere Therapeutics, Inc. Common Stock
|
49.60
|
-6.04% |
1.64M |
4.68B |
|
||
|
Veradermics, Incorporated
|
108.82
|
-5.43% |
670.50K |
4.55B |
|
||
|
Definium Therapeutics, Inc. Common Shares
|
32.10
|
-6.30% |
1.93M |
4.31B |
|
||
|
Edgewise Therapeutics, Inc. Common Stock
|
37.19
|
-2.64% |
1.14M |
4.04B |
|
||
|
Dianthus Therapeutics, Inc. Common Stock
|
72.09
|
-3.27% |
1.05M |
4.03B |
|
||
|
AbCellera Biologics Inc. Common Shares
|
11.80
|
-6.94% |
4.10M |
3.82B |
|
||
|
Tango Therapeutics, Inc.
|
22.04
|
-2.91% |
3.69M |
3.72B |
|
||
|
Telix Pharmaceuticals Limited American Depositary Shares
|
10.69
|
+1.14% |
324.83K |
3.63B |
|
||
|
Arcutis Biotherapeutics, Inc. Common Stock
|
28.82
|
-0.96% |
1.73M |
3.62B |
|
||
|
Legend Biotech Corporation American Depositary Shares
|
18.48
|
-6.67% |
2.96M |
3.59B |
|
||
|
Relay Therapeutics, Inc. Common Stock
|
16.28
|
-5.90% |
2.37M |
3.57B |
|
||
|
Acadia Pharmaceuticals Inc.
|
19.12
|
-2.99% |
1.67M |
3.29B |
|
||
|
Xenon Pharmaceuticals Inc
|
33.49
|
-2.45% |
1.07M |
3.24B |
|
||
|
Viking Therapeutics, Inc
|
25.17
|
-8.04% |
7.56M |
3.20B |
|
||
|
Tarsus Pharmaceuticals, Inc. Common Stock
|
68.07
|
-4.11% |
2.43M |
3.19B |
|
||
|
IDEAYA Biosciences, Inc. Common Stock
|
32.85
|
-2.95% |
654.77K |
3.17B |
|
||
|
Arcus Biosciences, Inc.
|
22.12
|
-3.07% |
1.42M |
2.82B |
|
||
|
Denali Therapeutics Inc. Common Stock
|
17.61
|
-3.98% |
2.30M |
2.81B |
|
||
|
Parabilis Medicines, Inc. Common Stock
|
22.75
|
-9.65% |
1.11M |
2.81B |
|
||
|
Celcuity Inc. Common Stock
|
56.58
|
-6.17% |
4.31M |
2.77B |
|
||
|
Enliven Therapeutics, Inc. Common Stock
|
37.32
|
-5.11% |
1.19M |
2.73B |
|
||
|
Nurix Therapeutics, Inc. Common stock
|
24.42
|
-2.12% |
3.69M |
2.67B |
|
||
|
Dyne Therapeutics, Inc. Common Stock
|
14.25
|
-6.80% |
2.86M |
2.66B |
|
||
|
Zai Lab Limited American Depositary Shares
|
23.19
|
-1.36% |
843.21K |
2.60B |
|
||
|
Beam Therapeutics Inc. Common Stock
|
23.47
|
-5.10% |
1.65M |
2.42B |
|
||
|
ADMA Biologics, Inc.
|
10.68
|
-0.47% |
3.07M |
2.39B |
|
||
|
MBX Biosciences, Inc. Common Stock
|
49.61
|
-2.17% |
818.91K |
2.39B |
|
||
|
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
19.83
|
-3.83% |
1.94M |
2.37B |
|
||
|
Precigen, Inc. Common Stock
|
6.385
|
-11.26% |
5.48M |
2.29B |
|
||
|
Harmony Biosciences Holdings, Inc. Common Stock
|
37.95
|
-0.84% |
892.25K |
2.21B |
|
||
|
Aurinia Pharmaceuticals Inc
|
16.51
|
-1.32% |
736.08K |
2.20B |
|
||
|
Disc Medicine, Inc. Common Stock
|
56.84
|
+0.34% |
560.58K |
2.18B |
|
||
|
Celldex Therapeutics, Inc
|
27.53
|
-4.84% |
997.95K |
2.16B |
|
||
|
Viridian Therapeutics, Inc. Common Stock
|
19.03
|
-2.71% |
2.46M |
2.16B |
|
||
|
Fortrea Holdings Inc. Common Stock
|
22.49
|
-1.12% |
1.84M |
2.14B |
|
||
|
Vericel Corporation
|
40.13
|
-2.17% |
737.13K |
2.05B |
|
||
|
SELLAS Life Sciences Group, Inc. Common Stock
|
9.98
|
-11.99% |
15.76M |
2.02B |
|
||
|
Vera Therapeutics, Inc. Class A Common Stock
|
27.88
|
-2.42% |
1.29M |
2.01B |
|
||
|
Lakefront Biotherapeutics American Depositary Shares
|
29.90
|
-0.10% |
250.89K |
1.96B |
|
||
|
Pharvaris N.V. Ordinary Shares
|
27.74
|
-6.41% |
1.31M |
1.95B |
|
||
|
Immunome, Inc.
|
16.47
|
-5.34% |
1.30M |
1.94B |
|
||
|
ADARx Pharmaceuticals, Inc. Common Stock
|
17.65
|
-0.28% |
247.03K |
1.89B |
|
||
|
Agios Pharmaceuticals, Inc.
|
31.32
|
-3.09% |
952.66K |
1.87B |
|
||
|
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
3.465
|
-16.71% |
40.50M |
1.86B |
|
||
|
Novavax Inc
|
11.26
|
-12.17% |
9.87M |
1.86B |
|
||
|
Sarepta Therapeutics,, Inc. Common Stock
|
17.10
|
-3.88% |
9.86M |
1.81B |
|
||
|
Zymeworks Inc.
|
25.03
|
-2.80% |
631.86K |
1.80B |
|
||
|
Mineralys Therapeutics, Inc. Common Stock
|
20.30
|
-6.19% |
1.18M |
1.79B |
|
||
|
Palvella Therapeutics, Inc. Common Stock
|
120.30
|
-5.53% |
179.49K |
1.73B |
|
||
|
Mesoblast Limited American Depositary Shares
|
13.28
|
-4.80% |
615.69K |
1.72B |
|
||
|
Xencor, Inc.
|
22.85
|
-4.79% |
1.13M |
1.70B |
|
||
|
Septerna, Inc. Common Stock
|
36.35
|
-2.94% |
234.12K |
1.70B |
|
||
|
Trevi Therapeutics, Inc. Common Stock
|
11.88
|
-1.90% |
2.70M |
1.69B |
|
||
|
UroGen Pharma Ltd. Ordinary Shares
|
34.56
|
-5.60% |
1.05M |
1.69B |
|
||
|
Vir Biotechnology, Inc. Common Stock
|
9.96
|
-4.87% |
1.73M |
1.69B |
|
||
|
Braveheart Bio, Inc. Common Stock
|
18.71
|
-4.30% |
414.85K |
1.68B |
|
||
|
Biohaven Ltd.
|
10.78
|
-5.69% |
2.42M |
1.63B |
|
||
|
Zenas BioPharma, Inc. Common Stock
|
24.84
|
-2.20% |
661.65K |
1.62B |
|
||
|
Intellia Therapeutics, Inc
|
11.42
|
+0.71% |
8.22M |
1.60B |
|
||
|
Nuvation Bio Inc.
|
4.45
|
-6.32% |
4.47M |
1.56B |
|
||
|
Stoke Therapeutics, Inc. Common Stock
|
24.17
|
-1.79% |
880.12K |
1.56B |
|
||
|
Generate Biomedicines, Inc. Common Stock
|
12.09
|
-7.43% |
1.07M |
1.55B |
|
||
|
Maze Therapeutics, Inc. Common Stock
|
27.53
|
+0.18% |
1.02M |
1.53B |
|
||
|
Immunocore Holdings plc American Depositary Shares
|
29.40
|
-0.27% |
924.92K |
1.51B |
|
||
|
uniQure N.V.
|
21.78
|
-3.29% |
1.29M |
1.51B |
|
||
|
Ocular Therapeutix, Inc.
|
6.87
|
-6.91% |
2.76M |
1.51B |
|
||
|
Structure Therapeutics Inc. American Depositary Shares
|
21.08
|
-5.00% |
1.16M |
1.50B |
|
||
|
Innoviva, Inc. Common Stock
|
20.78
|
-0.38% |
550.48K |
1.50B |
|
||
|
Korsana Biosciences, Inc. Common Stock
|
32.38
|
-3.77% |
112.92K |
1.47B |
|
||
|
Kailera Therapeutics, Inc. Common Stock
|
11.25
|
-3.93% |
1.30M |
1.46B |
|
||
|
Ascentage Pharma Group International American Depository Shares
|
15.37
|
+4.63% |
15,091 |
1.44B |
|
||
|
Ultragenyx Pharmaceutical Inc.
|
14.54
|
-4.15% |
2.92M |
1.43B |
|
||
|
Absci Corporation Common Stock
|
8.25
|
-7.09% |
3.53M |
1.42B |
|
||
|
Hemab Therapeutics Holdings, Inc. Common Stock
|
30.07
|
-7.53% |
351.76K |
1.40B |
|
||
|
AnaptysBio, Inc. Common Stock
|
46.61
|
-4.31% |
413.64K |
1.39B |
|
||
|
Rapport Therapeutics, Inc. Common Stock
|
27.57
|
-6.76% |
411.26K |
1.32B |
|
||
|
Inhibrx Biosciences, Inc. Common Stock
|
89.83
|
-0.74% |
145.42K |
1.32B |
|
||
|
Oric Pharmaceuticals, Inc. Common Stock
|
12.35
|
-3.29% |
945.34K |
1.28B |
|
||
|
Tyra Biosciences, Inc. Common Stock
|
18.52
|
-2.73% |
648.95K |
1.27B |
|
||
|
GH Research PLC Ordinary Shares
|
18.15
|
-3.51% |
162.60K |
1.25B |
|
||
|
First Tracks Biotherapeutics, Inc. Ordinary Shares
|
34.46
|
-4.38% |
1.04M |
1.23B |
|
||
|
Nektar Therapeutics
|
35.78
|
-5.14% |
783.88K |
1.22B |
|
||
|
Kardigan, Inc. Common Stock
|
13.03
|
-6.12% |
717.61K |
1.22B |
|
||
|
LB Pharmaceuticals Inc Common Stock
|
36.74
|
+0.14% |
724.73K |
1.19B |
|
||
|
Taysha Gene Therapies, Inc. Common Stock
|
3.62
|
-2.95% |
2.75M |
1.18B |
|
||
|
Omeros Corporation
|
16.20
|
-13.78% |
3.96M |
1.17B |
|
||
|
Syndax Pharmaceuticals, Inc.
|
12.90
|
-5.49% |
2.84M |
1.15B |
|
||
|
Damora Therapeutics, Inc. Ordinary Shares
|
18.44
|
-1.60% |
836.71K |
1.14B |
|
||
|
Alpha Tau Medical Ltd. Ordinary Shares
|
12.29
|
-6.61% |
778.49K |
1.14B |
|
||
|
Iambic Therapeutics, Inc. Common Stock
|
23.81
|
+0.00% |
2.94M |
1.13B |
|
||
|
Bicara Therapeutics Inc. Common Stock
|
16.78
|
-4.77% |
819.73K |
1.11B |
|
||
|
Nanobiotix S.A. American Depositary Shares
|
21.30
|
-4.18% |
77,772 |
1.08B |
|
||
|
Vor Biopharma Inc. Common Stock
|
18.03
|
-6.77% |
733.08K |
1.07B |
|
||
|
Avalyn Pharma Inc. Common Stock
|
23.66
|
-3.98% |
291.43K |
1.05B |
|
||
|
Immatics N.V. Ordinary Shares
|
6.73
|
-5.74% |
1.15M |
1.02B |
|
||
|
Replimune Group, Inc.
|
10.86
|
-7.57% |
1.71M |
1.02B |
|
||
|
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
6.79
|
-3.96% |
2.22M |
1.01B |
|
||
|
Janux Therapeutics, Inc. Common Stock
|
16.51
|
-4.68% |
765.88K |
1.01B |
|
||
|
Mannkind Corporation
|
3.04
|
-4.70% |
2.61M |
977.50M |
|
||
|
Seaport Therapeutics, Inc. Common Stock
|
17.83
|
+1.31% |
184.54K |
954.45M |
|
||
|
Latigo Biotherapeutics, Inc. Common Stock
|
14.00
|
-5.15% |
207.38K |
928.19M |
|
||
|
Savara Inc.
|
4.45
|
-6.12% |
2.23M |
914.30M |
|
||
|
MeiraGTx Holdings plc Ordinary Shares
|
9.28
|
-6.17% |
666.43K |
891.28M |
|
||
|
Alto Neuroscience Inc.
|
21.94
|
-3.01% |
648.32K |
860.97M |
|
||
|
Rigel Pharmaceuticals Inc. (New)
|
45.97
|
-2.71% |
141.43K |
858.71M |
|
||
|
SL Science Holding Limited Ordinary Shares
|
1.53
|
-1.29% |
24,822 |
857.96M |
|
||
|
Jade Biosciences, Inc. Common Stock
|
13.47
|
-2.11% |
980.98K |
856.66M |
|
||
|
Aktis Oncology, Inc. Common stock
|
15.06
|
-5.93% |
394.80K |
837.63M |
|
||
|
Arbutus Biopharma Corporation Common Stock
|
4.22
|
-1.63% |
4.54M |
836.01M |
|
||
|
Cullinan Therapeutics, Inc. Common Stock
|
12.93
|
-7.64% |
1.12M |
832.11M |
|
||
|
Monte Rosa Therapeutics, Inc. Common Stock
|
9.74
|
-3.75% |
883.19K |
830.95M |
|
||
|
Odyssey Therapeutics, Inc. Common Stock
|
17.17
|
-2.28% |
218.38K |
825.16M |
|
||
|
ArriVent BioPharma, Inc. Common Stock
|
16.66
|
-0.77% |
1.33M |
821.47M |
|
||
|
MoonLake Immunotherapeutics Class A Ordinary Shares
|
9.55
|
-6.92% |
1.38M |
812.77M |
|
||
|
Kura Oncology, Inc.
|
9.08
|
-6.39% |
1.78M |
807.76M |
|
||
|
SpyGlass Pharma, Inc. Common Stock
|
24.00
|
-2.91% |
70,647 |
802.75M |
|
||
|
Corvus Pharmaceuticals, Inc.
|
9.52
|
-3.35% |
1.04M |
800.83M |
|
||
|
Ardelyx, Inc.
|
3.09
|
-5.50% |
5.78M |
797.80M |
|
||
|
Alumis Inc. Common Stock
|
6.12
|
-3.01% |
2.50M |
792.14M |
|
||
|
Verastem, Inc.
|
8.65
|
-6.28% |
6.09M |
783.37M |
|
||
|
Helus Pharma Inc.
|
10.55
|
-4.52% |
1.31M |
770.88M |
|
||
|
Geron Corp
|
1.17
|
-4.88% |
3.95M |
751.69M |
|
||
|
Apnimed, Inc. Common Stock
|
17.76
|
-2.66% |
235.05K |
739.36M |
|
||
|
Obsidian Therapeutics, Inc. Common Stock
|
11.77
|
-3.52% |
297.68K |
727.07M |
|
||
|
Adlai Nortye Group Ltd. American Depositary Shares
|
11.03
|
-8.77% |
336.59K |
710.31M |
|
||
|
Inventiva S.A. American Depository Shares
|
2.94
|
-5.47% |
4.85M |
694.53M |
|
||
|
Ginkgo Bioworks Holdings, Inc.
|
10.27
|
-12.67% |
3.55M |
691.58M |
|
||
|
Sana Biotechnology, Inc. Common Stock
|
2.27
|
-8.28% |
3.09M |
679.55M |
|
||
|
Lexicon Pharmaceuticals, Inc.
|
1.52
|
-7.88% |
2.01M |
676.33M |
|
||
|
4D Molecular Therapeutics, Inc. Common Stock
|
12.14
|
-5.67% |
794.53K |
670.66M |
|
||
|
OmniAb, Inc. Common Stock
|
4.59
|
-2.96% |
969.41K |
667.34M |
|
||
|
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
9.36
|
-2.80% |
9,029 |
662.48M |
|
||
|
Immix Biopharma, Inc. Common Stock
|
7.98
|
-8.06% |
1.47M |
661.57M |
|
||
|
Achieve Life Sciences, Inc.
|
6.38
|
-8.46% |
1.99M |
657.79M |
|
||
|
MiMedx Group, Inc
|
4.43
|
-5.34% |
2.73M |
646.49M |
|
||
|
Annexon, Inc. Common Stock
|
3.41
|
-5.28% |
5.11M |
646.46M |
|
||
|
Design Therapeutics, Inc. Common Stock
|
10.31
|
-1.62% |
854.55K |
645.22M |
|
||
|
Gyre Therapeutics, Inc. Common Stock
|
6.08
|
-5.00% |
142.87K |
644.69M |
|
||
|
Aura Biosciences, Inc. Common Stock
|
6.10
|
-3.79% |
762.44K |
632.60M |
|
||
|
Prime Medicine, Inc. Common Stock
|
3.47
|
-3.88% |
4.38M |
629.38M |
|
||
|
Attovia Therapeutics, Inc. Common Stock
|
13.73
|
-7.10% |
977.90K |
626.79M |
|
||
|
Candel Therapeutics, Inc. Common Stock
|
8.19
|
-8.08% |
1.50M |
626.69M |
|
||
|
Wave Life Sciences Ltd. Ordinary Shares
|
3.13
|
-1.88% |
3.28M |
616.76M |
|
||
|
Nuvectis Pharma, Inc. Common Stock
|
18.60
|
-1.74% |
158.42K |
607.18M |
|
||
|
Avalo Therapeutics, Inc. Common Stock
|
11.27
|
-6.16% |
969.41K |
604.41M |
|
||
|
Solid Biosciences Inc. Common Stock
|
5.53
|
-3.66% |
1.40M |
592.96M |
|
||
|
Zevra Therapeutics, Inc. Common Stock
|
9.94
|
-3.21% |
593.88K |
590.27M |
|
||
|
Olema Pharmaceuticals, Inc. Common Stock
|
6.58
|
-4.22% |
1.08M |
575.73M |
|